Stem Cell Therapy in Stargardt Disease: A Systematic Review

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Genetics

Background:

• Stargardt disease is a leading inherited macular dystrophy.
• Current treatments are limited, necessitating novel therapeutic approaches.
• Stem cell therapy offers a potential regenerative strategy.

Purpose of the Study:

• To review the current literature on stem cell therapy for Stargardt disease.
• To evaluate the safety and efficacy of different stem cell types and delivery methods.
• To identify gaps in knowledge for future research.

Main Methods:

• Comprehensive literature search for animal and human clinical trials.
• Analysis of studies using various stem cell sources (embryonic, mesenchymal, bone marrow).
• Evaluation of different administration routes (subretinal, intravitreal, suprachoroidal).

Main Results:

• Eleven human and two animal trials were identified.
• Diverse stem cell types and delivery methods have been explored.
• Preliminary evidence suggests potential for visual function improvement.

Conclusions:

• Stem cell therapy is a promising avenue for Stargardt disease.
• Further research is essential to determine optimal cell types and delivery methods.
• Long-term safety and efficacy require comprehensive investigation.